Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

Infection Control and Hospital Epidemiology - Tập 31 Số 05 - Trang 431-455 - 2010
Stuart H. Cohen1, Dale N. Gerding2, Stuart Johnson2, Ciarán P. Kelly3, Vivian G. Loo4, L. Clifford McDonald5, Jean‐Louis Pépin6, Mark H. Wilcox7
1Department of Internal Medicine, Division of Infectious and Immunologic Diseases, University of California Davis Medical Center, Sacramento, California
2Research Service, Edward Hines Jr. Veterans Affairs Hospital, and Infectious Disease Division, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois
3Division of Gastroenterology Beth Israel Deaconess Medical Center, Boston, Massachusetts
4Department of Microbiology, McGill University Health Center, Montreal, Quebec, Canada
5Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
6Department of Microbiology and Infectious Diseases, University of Sherbrooke, Quebec, Canada
7Department of Microbiology, Leeds Teaching Hospitals National Health Service Trust and Institute of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom

Tóm tắt

Since publication of the Society for Healthcare Epidemiology of America position paper onClostridium difficileinfection in 1995, significant changes have occurred in the epidemiology and treatment of this infection.C. difficileremains the most important cause of healthcare-associated diarrhea and is increasingly important as a community pathogen. A more virulent strain ofC. difficilehas been identified and has been responsible for more-severe cases of disease worldwide. Data reporting the decreased effectiveness of metronidazole in the treatment of severe disease have been published. Despite the increasing quantity of data available, areas of controversy still exist. This guideline updates recommendations regarding epidemiology, diagnosis, treatment, and infection control and environmental management.

Từ khóa


Tài liệu tham khảo

10.1093/infdis/162.3.678

10.1056/NEJMcp011603

10.1086/519178

1984, Dis Mon, 30, 1

10.1016/j.ajic.2005.04.240

10.1093/ageing/28.2.107

10.1016/j.jhin.2004.01.019

10.1164/rccm.200405-644ST

10.2307/30146511

10.1086/589906

10.1016/j.jinf.2007.09.015

10.1097/01.sla.0000236628.79550.e5

10.1016/j.diagmicrobio.2005.09.008

10.1086/430311

10.1093/jac/dkn313

10.1128/AAC.49.3.1157-1159.2005

10.1128/AAC.50.5.1890-1892.2006

10.1099/jmm.0.05037-0

10.1001/archinte.1986.00360130117016

10.1093/jac/dki357

2006, Clin Microbiol Infect, 12, 2

10.1016/S0732-8893(98)00139-4

1988, Am J Epidemiol, 127, 1289, 10.1093/oxfordjournals.aje.a114921

10.1086/506351

10.2307/30141397

10.1086/506349

10.2307/30141374

10.1056/NEJM200002103420604

1996, Infect Control Hosp Epidemiol, 17, 180

10.1016/0732-8893(86)90092-1

10.1086/519201

10.1016/S0140-6736(97)08062-8

10.1093/infdis/143.1.42

1992, J Clin Microbiol, 30, 1837, 10.1128/JCM.30.7.1837-1840.1992

10.1017/S095026880005696X

10.1056/NEJM198901263200402

10.1086/424667

10.7326/0003-4819-117-4-297

1986, Lancet, 2, 11

10.1007/BF02013056

1990, Risk factors for Clostridium difficile toxin-associated diarrhea, infect Control Hosp Epidemiol, 11, 283

1994, N J Med, 91, 327

10.1086/429513

1989, Lancet, 2, 866

2006, Guidelines for design and construction of health care facilities

10.1086/502286

10.1016/S0195-6701(03)00149-X

10.1053/jhin.2001.0962

10.1016/0002-9343(90)90462-M

10.2307/30142367

10.2307/30141489

10.1093/ageing/21.4.245

10.1016/0002-9343(91)90359-6

10.2307/30148335

10.1056/NEJM199401273300406

10.1136/bmj.1.6071.1246

10.1128/JCM.00684-08

10.1016/S0002-9343(95)00016-X

10.1016/S0002-9343(95)00057-7

10.1128/JCM.01305-07

10.3201/eid1205.051350

2005, Clin Microbiol Infect, 11, 57

2009, Clostridium difficile toxin detection assays

10.1016/S1473-3099(08)70233-0

2007, Proceedings of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

10.1086/502596

1989, J Clin Microbiol, 27, 2386, 10.1128/JCM.27.10.2386-2387.1989

10.1086/502129

10.1136/bmj.323.7310.411

10.1086/501784

10.7326/0003-4819-130-2-199901190-00006

2002, MMWR Recomm Rep, 51, 1

10.1016/0195-6701(94)90063-9

10.1093/ageing/27.5.561

10.1086/422523

10.1053/ic.1998.v26.a84773

10.1093/infdis/166.3.561

2008, Clin Microbiol Infect, 14, 2

1998, J Clin Microbiol, 36, 2240, 10.1128/JCM.36.8.2240-2247.1998

10.1128/JCM.00032-08

10.1016/j.jhin.2005.01.017

1995, J Clin Microbiol, 33, 3169, 10.1128/JCM.33.12.3169-3173.1995

10.1586/14737159.1.1.61

10.1086/511798

10.1093/qjmed/93.3.175

1984, J Clin Microbiol, 19, 77, 10.1128/JCM.19.1.77-78.1984

10.1503/cmaj.1040876

10.1016/S0195-6701(03)00088-4

10.7326/0003-4819-129-12-199812150-00004

10.1309/U8ATL52Q60XYAVX6

10.1007/s100960000297

10.1128/JCM.42.8.3837-3840.2004

10.1128/JCM.42.10.4863-4865.2004

10.1053/jhin.1999.0253

1979, J Clin Microbiol, 9, 214, 10.1128/jcm.9.2.214-219.1979

10.7326/0003-4819-135-6-200109180-00012

10.1016/0732-8893(88)90045-4

10.1016/0732-8893(87)90051-4

10.2307/30145209

10.1128/JCM.40.6.2079-2083.2002

10.1086/498027

10.1086/322616

10.1038/sj.bmt.1701773

10.1007/BF02710173

10.1093/clinids/17.1.109

10.1001/archsurg.1991.01410260131019

10.1128/AAC.35.1.208

10.1056/NEJM199911253412203

10.1503/cmaj.1041104

10.2307/30147068

10.1128/JCM.44.3.1145-1149.2006

10.1016/S0195-6701(02)00400-0

2001, Epidemiol Infect, 126, 343, 10.1017/S095026880100557X

10.1086/318149

10.1016/S0002-9343(96)90008-X

2006, Proceedings of The 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, 115

2006, Proceedings of The 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, 108

10.1086/502602

1994, Am J Gastroenterol, 89, 519

10.1086/320736

1999, J Clin Microbiol, 37, 3044, 10.1128/JCM.37.9.3044-3047.1999

1997, Am J Gastroenterol, 92, 739

10.1093/clinids/20.6.1560

1995, MMWR Recomm Rep, 44, 1

10.1016/S0732-8893(02)00413-3

10.1038/nature07822

10.1128/JCM.01484-07

10.1128/JCM.02023-06

10.1128/JCM.02364-05

10.1099/mic.0.28155-0

1999, J Clin Microbiol, 37, 461, 10.1128/JCM.37.2.461-463.1999

10.1099/jmm.0.45989-0

10.1016/S0140-6736(00)03592-3

10.1016/S0195-6701(03)00266-4

10.1053/ic.1999.v27.a90941

10.1086/521854

10.1016/0002-9343(81)90553-2

2003, J Gend Specif Med, 6, 27

10.3201/eid0502.990224

10.1016/S0149-2918(00)87980-1

10.1093/infdis/169.1.127

10.1001/jama.294.23.2989

10.1128/JCM.42.9.4316-4318.2004

10.1136/gut.2003.028803

10.1016/S0163-4453(98)94207-4

10.1097/00007611-199709000-00004

2005, MMWR Morb Mortal Wkly Rep, 54, 1201

2007, Euro Surveill, 12, E0701113

2008, Euro Surveill, 13, 18942

2005, Ned Tijdschr Geneeskd, 149, 2087

2005, CDR Weekly, 15

10.1016/S0140-6736(05)67420-X

2006, difficile in 7 provinces. Can Med Assoc, 174, 607

10.1086/502539

10.1086/430315

10.3201/eid1205.051064

10.1086/522676

10.1086/338260

10.1086/501997

10.1111/j.1532-5415.1993.tb06759.x

Proceedings of the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America

10.1086/502023

10.1136/gut.41.3.366

10.1093/jac/dkh176

1979, Can Med Assoc J, 121, 1193

10.1016/j.vaccine.2003.11.030

1990, Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines, Clinical Practice Guidelines: Directions for a New Program

10.1086/367657

1981, Scand J Infect Dis Suppl, 26, 42

10.2307/30141083

10.1093/jac/23.1.167

10.1086/340536

10.1136/bmj.2.6153.1667

10.1016/S0002-9343(03)00420-0

10.1136/gut.27.10.1169

10.1086/322675

1983, Lancet, 2, 1043

10.1080/00365529850171666

10.1503/cmaj.050350

10.1086/497832

10.1086/596315

10.1086/511870

10.1086/506354

1999, Int J Clin Pharmacol Res, 19, 83

10.1086/501126

10.1016/0016-5085(91)90526-Q

1998, Am J Gastroenterol, 93, 1873, 10.1111/j.1572-0241.1998.00541.x

10.2307/30145589

10.1086/496986

10.1136/bmj.39231.599815.55

10.1093/clinids/18.2.181

10.1086/511789

10.1128/CMR.18.2.247-263.2005

10.1086/381551

10.1056/NEJMoa051639

10.1086/519258

10.1056/NEJMoa051590

10.1093/jac/dkh127

10.1016/0140-6736(90)91605-A

10.1093/jac/dkh285

10.1093/infdis/143.1.51

10.1016/S0195-6701(03)00115-4

10.1093/infdis/142.3.408

10.1093/jac/40.5.707

10.1093/infdis/146.6.727

10.1086/502278

10.7326/0003-4819-128-12_Part_1-199806150-00005

1989, J Infect Dis, 159

2000, J Clin Microbiol, 38, 2386, 10.1128/JCM.38.6.2386-2388.2000

10.1093/clind/15.4.573

10.1093/clinids/6.Supplement_1.S235

10.1007/s10350-004-0672-2

10.1007/s10350-006-0511-8

10.1086/342334

2007, Proceedings of the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

10.1007/BF01666909

10.1086/519265

10.1111/j.1348-0421.1981.tb00036.x

10.1111/j.1572-0241.2007.01539.x

10.7326/0003-4819-120-4-199402150-00003

10.1093/infdis/151.3.476

2005, Cochrane Database Syst Rev, 19, CD003543

1981, Gastroenterology, 81, 5, 10.1016/0016-5085(81)90644-2

1998, J Hosp Infect, 40, 1

10.1001/archpedi.1935.01970020105010

2001, J Antimicrob Chemother, 47, 43

1987, Am J Gastroenterol, 82, 389

2005, Cochrane Database Syst Rev, 1, CD004610

10.1007/BF01690732

10.1093/jac/dkh278

10.4065/73.10.943

10.1093/clinids/22.5.813

Thông tin
Thông tin xuất bản

Infection Control and Hospital Epidemiology

Tập 31 Số 05

431-455

Thông tin tác giả